INDIANAPOLIS--(BUSINESS WIRE)--CoLucid Pharmaceuticals, Inc., a development stage biopharmaceutical company developing new treatment for migraine headaches, pain and other neurological disorders, has announced James F. White, Ph.D., as President and Chief Executive Officer. Additionally, White has been elected to serve as a member of the CoLucid Board of Directors.
